Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) Return on Invested Capital (2022 - 2024)

Century Therapeutics (IPSC) has disclosed Return on Invested Capital for 3 consecutive years, with 345.68% as the latest value for Q4 2024.

  • Quarterly Return on Invested Capital rose 34642.0% to 345.68% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 345.68% through Dec 2024, up 34642.0% year-over-year, with the annual reading at 0.01% for FY2025, 28498.0% down from the prior year.
  • Return on Invested Capital for Q4 2024 was 345.68% at Century Therapeutics, up from 0.69% in the prior quarter.
  • The five-year high for Return on Invested Capital was 345.68% in Q4 2024, with the low at 0.81% in Q1 2024.
  • Average Return on Invested Capital over 3 years is 37.86%, with a median of 0.6% recorded in 2023.
  • Peak annual rise in Return on Invested Capital hit 34642bps in 2024, while the deepest fall reached -37bps in 2024.
  • Over 3 years, Return on Invested Capital stood at 0.42% in 2022, then tumbled by -77bps to 0.74% in 2023, then skyrocketed by 47094bps to 345.68% in 2024.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 345.68%, 0.69%, and 0.73% for Q4 2024, Q3 2024, and Q2 2024 respectively.